291 related articles for article (PubMed ID: 60287)
1. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. III. Alterations of splenic B and T cells in Friend virus-infected mice.
Cerny J; Essex M; Thomas DB
Int J Cancer; 1976 Aug; 18(2):197-204. PubMed ID: 60287
[TBL] [Abstract][Full Text] [Related]
2. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens.
Cerny J; Hensgen PA; Fistel SH; Demler LM
Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288
[TBL] [Abstract][Full Text] [Related]
3. Expression of virus-associated antigens and immune cell functions during spontaneous regression of the Friend viral murine leukemia.
Cerny J; Essex M; Rich MA; Hardy WD
Int J Cancer; 1975 Feb; 15(2):351-65. PubMed ID: 47847
[TBL] [Abstract][Full Text] [Related]
4. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. I. Virus replication in lymphocytes infected with Friend virus and cultures in diffusion chambers in vivo.
Cerny J; Fistel SH; Hensgen PA
Int J Cancer; 1976 Aug; 18(2):176-88. PubMed ID: 182644
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
Friedman H; Kateley JR
Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
[TBL] [Abstract][Full Text] [Related]
6. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus.
Cerny J; Waner EB
J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504
[TBL] [Abstract][Full Text] [Related]
7. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus.
Risser R
J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285
[TBL] [Abstract][Full Text] [Related]
8. Target cell heterogeneity in murine leukemia virus infection. II. Demonstration of Friend leukemia-virus-permissive and non-permissive subsets of splenic T cells.
Isaak DD; Cerny J
Int J Cancer; 1981; 27(4):505-12. PubMed ID: 6974139
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
Kumar V; Caruso T; Bennett M
J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914
[TBL] [Abstract][Full Text] [Related]
10. Functional heterogeneity of murine lymphoid cells. V. Lymphocytes lacking detectable surface theta or immunoglobulin determinants.
Stobo JD; Rosenthal AS; Paul WE
J Exp Med; 1973 Jul; 138(1):71-88. PubMed ID: 4123830
[TBL] [Abstract][Full Text] [Related]
11. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin and other surface antigens of cells of the immune system.
Takahashi T; Old LJ; McIntire KR; Boyse EA
J Exp Med; 1971 Oct; 134(4):815-32. PubMed ID: 4106485
[TBL] [Abstract][Full Text] [Related]
13. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
14. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
15. Cell-free transmission of Fv-4 resistance gene product controlling Friend leukemia virus-induced leukemogenesis: a unique mechanism for interference with viral infection.
Kitagawa M; Aizawa S; Kamisaku H; Ikeda H; Hirokawa K; Sado T
Blood; 1995 Aug; 86(4):1557-63. PubMed ID: 7632964
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic heterogeneity of leukemias associated with Friend MuLV infection: studies on T-cell lymphomas and null cell leukemias in euthymic and thymus-deficient mice.
Isaak DD; Asjö B; Hoover EA; Cerny J
Leuk Res; 1984; 8(4):617-27. PubMed ID: 6332242
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes.
Miyazawa M; Nishio J; Chesebro B
J Exp Med; 1988 Nov; 168(5):1587-605. PubMed ID: 3141552
[TBL] [Abstract][Full Text] [Related]
18. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
[TBL] [Abstract][Full Text] [Related]
19. A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host response.
Podschwadt P; Malyshkina A; Windmann S; Werner T; Hansen W; Bayer W
Retrovirology; 2022 Dec; 19(1):29. PubMed ID: 36527061
[TBL] [Abstract][Full Text] [Related]
20. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph nodes.
Isaak DD; Price JA; Reinisch CL; Cerny J
J Immunol; 1979 Oct; 123(4):1822-8. PubMed ID: 314476
[No Abstract] [Full Text] [Related]
[Next] [New Search]
